T1	Participants 105 132	HIV-HCV-coinfected patients
T2	Participants 312 339	HIV-HCV-coinfected patients
T3	Participants 349 398	HIV and HCV genotype 1- and 4-coinfected subjects
T4	Participants 893 929	A total of 67 patients were included
